NCT06601244View on ClinicalTrials.gov

Pharmacokinetic Study in the Biliary Complications During Liver Transplantation

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Liver Transplantation
Interventions
OTHER

Pharmacokinetic

Biliary and blood concentration of the DALBAVANCINE

Trial Locations (1)

38700

University Hospital Of Grenoble, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06601244 - Pharmacokinetic Study in the Biliary Complications During Liver Transplantation | Biotech Hunter | Biotech Hunter